Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Abbott Labs

They promise revenue growth, profit -- and safety.

Tech Stock Correction: Buy These 2 Healthcare Stocks on the Dip

Lumen Technologies

Nokia

These companies' stocks have bucked the trend and are holding on to their gains.

3 Tech Stocks Holding Strong Amid the Market Volatility

Alphabet

The Dogecoin bull thesis can be easily debunked. Instead of tossing your money down the drain, put it to work in these high-quality businesses.

Ignore Dogecoin: These Stocks Will Make You Rich

These 3 Things Make a Healthcare Stock Evergreen

Etsy

The volatile cryptocurrency is no match for these two excellent companies.

2 Unstoppable Growth Stocks That Are Better Buys Than Dogecoin

Intuitive Surgical (ISRG) continues to gain traction from improving adoption of da Vince Surgical System. However, rise in production costs is a woe.

Here's Why You Should Retain Intuitive Surgical (ISRG) Now

Increased efficiency and precision has been driving demand for robotics across industries, making it wise to look at names like Deere & Co. (DE), Cognex (CGNX), ABB (ABB) and Intuitive Surgical (ISRG)

5 Stocks to Watch as Automation Drives Demand for Robotics

A strong earnings report lifted the healthcare stock last month.

Why Intuitive Surgical Stock Jumped 17% in April

Things are looking up for the robotic surgical systems leader.

Intuitive Surgical Is Back in Growth Mode: Can It Keep the Momentum Going?

Asensus Surgical

Boston Scientific

Johnson & Johnson

Stryker

Rapid innovation is boosting the robotic surgery space, putting the spotlight on Johnson & Johnson (JNJ), Stryker (SYK), Boston Scientific (BSX), Intuitive Surgical (ISRG) and Asensus Surgical (ASXC).

Innovation Drives Robotic-Assisted Surgery: 5 Stocks to Watch

CrowdStrike

Green Thumb Industries Inc.

Dogecoin, the much-hyped cryptocurrency, can't hold a candle to these high-quality stocks over the long run.

3 Unstoppable Stocks That Can Crush Dogecoin

Illumina

The advice of Warren Buffett's biggest influencers supports these solid picks.

2 of the Best Healthcare Stocks You'll Find Today

Pfizer

Teladoc

Don't wait to snag these three golden eggs for your basket of stocks.

3 Healthcare Stocks That Could Be Millionaire-Makers

From dividends to growth to overall stability, these stocks will give your portfolio a great mix.

3 Top Healthcare Stocks to Buy and Hold for the Next 10 Years

The stock price of Intuitive Surgical has seen an 8% rise over the last five trading days, while it's up 12% over the last ten trading sessions, after the company announced better than expected Q1 results. Intuitive Surgical's Q1 revenue of 1.3 billion was ahead of $1.2 billion revenue forecast.

What's Next For Intuitive Surgical Stock After The Recent 12% Rise?

SUNNYVALE, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the appointment of Dr. Monica P. Reed, a former AdventHealth executive, to its board of directors effective April 22, 2021.

Intuitive Appoints Dr. Monica P. Reed to its Board of Directors

Block

Each of them has what it takes to deliver tremendous returns.

$5,000 Invested in These 3 Stocks Should Make You a Fortune Over the Next 10 Years

Pandemic-fueled healthcare trends bode well for the maker of the da Vinci surgical robot.

10 Words From Intuitive Surgical's CEO That Could Mean Billions for Investors

Intuitive Surgical, Inc. (ISRG) Presents at Annual Shareholder Meeting Broker Conference Call - (Transcript)

ISRG's Q1 was great, primarily because of the company's growth fully reigniting.

Intuitive Surgical Remains A Good Investment, But Take Note Of The Valuation

ABB Ltd.

iRobot

Nuance Communications

Teradyne

Investing in the latest trends will help you stay ahead of the markets, and you can never go wrong with robotics stocks in that respect. The post 5 Robotics Stocks That Will Make Your Life Easier appeared first on InvestorPlace.

5 Robotics Stocks That Will Make Your Life Easier

Intuitive Surgical, Inc. (ISRG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Intuitive Surgical, Inc. (ISRG) Surges 9.9%: Is This an Indication of Further Gains?

The robotic surgery leader is enjoying a rebound in demand.

Why Intuitive Surgical Stock Surged Today

Edwards Lifesciences

Edwards Lifesciences Corp. (NYSE:EW) and Intuitive Surgical Inc. (NASDAQ:ISRG) are on the Wall Street radar this week.

Edwards Lifesciences and Intuitive Surgical: Right Place, Right Time and Wide Moats

Shares of Intuitive Surgical jumped as much as 9.8% on Wednesday to a record high of $891.15 after the robotic surgery company crushed first quarter earnings.  The stock movement pushed Intuitive Surgical's market capitalization past $100 billion for the first time ever.

News for Intuitive Surgical Stock (ISRG)